Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of $40.00.
In a report released today, Stephen Gengaro from Stifel Nicolaus maintained a Hold rating on Blink Charging Co (BLNK – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback